Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Anasetti

Showing results (131-140 of 222) with videos related to

Pageof 23
Sort By:
Bone Marrow Transplantation|January 1, 1992
Changing trends in marrow transplantation for aplastic anemiaR Storb, G Longton, C Anasetti, et al.
The New England Journal of Medicine|December 26, 2001
Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantationE W Petersdorf, J A Hansen, P J Martin, et al.
Transplantation Proceedings|February 1, 1993
Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantationE W Petersdorf, A G Smith, E M Mickelson, et al.
Bone Marrow Transplantation|June 1, 1991
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survivalK Doney, L D Fisher, F R Appelbaum, et al.
Bone Marrow Transplantation|May 1, 1991
Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3C Anasetti, P J Martin, R Storb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapyC H Weaver, F R Appelbaum, F B Petersen, et al.
Blood|April 1, 1993
The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantationE W Petersdorf, A G Smith, E M Mickelson, et al.
Blood|November 10, 1998
Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipientE W Petersdorf, T A Gooley, C Anasetti, et al.
Bone Marrow Transplantation|December 2, 2000
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicitiesT Furlong, R Storb, C Anasetti, et al.
Bone Marrow Transplantation|April 2, 2013
Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myelomaT Nishihori, J L Ochoa-Bayona, J Kim, et al.
Pageof 23

Showing results (131-140 of 222) with videos related to

Sort By:
Pageof 23
Bone Marrow Transplantation|January 1, 1992
Changing trends in marrow transplantation for aplastic anemiaR Storb, G Longton, C Anasetti, et al.
The New England Journal of Medicine|December 26, 2001
Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantationE W Petersdorf, J A Hansen, P J Martin, et al.
Transplantation Proceedings|February 1, 1993
Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantationE W Petersdorf, A G Smith, E M Mickelson, et al.
Bone Marrow Transplantation|June 1, 1991
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survivalK Doney, L D Fisher, F R Appelbaum, et al.
Bone Marrow Transplantation|May 1, 1991
Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3C Anasetti, P J Martin, R Storb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapyC H Weaver, F R Appelbaum, F B Petersen, et al.
Blood|April 1, 1993
The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantationE W Petersdorf, A G Smith, E M Mickelson, et al.
Blood|November 10, 1998
Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipientE W Petersdorf, T A Gooley, C Anasetti, et al.
Bone Marrow Transplantation|December 2, 2000
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicitiesT Furlong, R Storb, C Anasetti, et al.
Bone Marrow Transplantation|April 2, 2013
Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myelomaT Nishihori, J L Ochoa-Bayona, J Kim, et al.
Pageof 23